-
Marcando el rumbo a seguir: la Directora Ejecutiva del CRI analiza 2020 y el prometedor futuro
La Directora Ejecutiva del CRI, la Dra. Jill O’Donnell-Tormey, Ph. D., habla sobre los avances de la…
-
Kidney Cancer Awareness Month: 2021 Immunotherapy Research Updates
This March for Kidney Cancer Awareness Month, we look at new research, new treatments, and how we’re…
-
Colorectal Cancer Awareness Month: 2021 Immunotherapy Research Updates
This March for Colorectal Cancer Awareness Month, we look at new research, new treatments, and how we’re…
-
Multiple Myeloma Awareness Month: 2021 Immunotherapy Research Updates
This March for Multiple Myeloma Awareness Month, we look at new research, new treatments, and how we’re…
-
Combustible para la lucha: el efecto del metabolismo del cáncer sobre el sistema inmunitario, con el Dr. Greg Delgoffe
Greg Delgoffe, beneficiario del programa Lloyd J. Old STAR del CRI, está investigando el efecto del metabolismo…
-
Dr. Terence Friedlander Answers Questions on Bladder Cancer and Immunotherapy from the CRI Virtual Immunotherapy Patient Summit
Terence Friedlander, MD, answers questions about immunotherapy for bladder cancer from the 2020 CRI Virtual Immunotherapy Patient…
-
Dr. Elizabeth M. Jaffee Answers Questions on Pancreatic Cancer and Immunotherapy from the CRI Virtual Immunotherapy Patient Summit
Dr. Elizabeth Jaffee answers questions on immunotherapy for pancreatic cancer from the 2020 CRI Virtual Immunotherapy Patient…
-
Cervical Cancer Awareness Month: 2021 Immunotherapy Research Updates
This January for Cervical Cancer Awareness Month, we look at new research, new treatments, and how we’re…
-
Dr. Kunle Odunsi Answers Questions About Ovarian Cancer and Immunotherapy From the 2020 CRI Virtual Immunotherapy Patient Summit
Dr. Kunle Odunsi of Roswell Park Comprehensive Cancer Center answers questions about ovarian cancer and immunotherapy from…
